Renamed to Artivion, Inc. (AORT) in March 2022
CRY - CryoLife, Inc.
NYSE
->
Healthcare
->
Medical Devices
Kennesaw,
United States
Type: Equity
CRY price evolution
CRY
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.59 | $50.47 | $56.55 | $61.41 |
| Short term investments | $0.54 | $0.55 | $0.55 | $0.55 |
| Net receivables | $55.18 | $53.28 | $50.74 | $48.75 |
| Inventory | $78.32 | $76.36 | $73.38 | $73.04 |
| Total current assets | $257.34 | $238.05 | $235.68 | $234.59 |
| Long term investments | ||||
| Property, plant & equipment | $83.89 | $84.78 | $70.57 | $51.65 |
| Goodwill & intangible assets | $460.23 | $471.32 | $472.19 | $487.12 |
| Total noncurrent assets | $561.31 | $572.44 | $559.15 | $554.82 |
| Total investments | $0.54 | $0.55 | $0.55 | $0.55 |
| Total assets | $818.65 | $810.5 | $794.83 | $789.4 |
| Current liabilities | ||||
| Accounts payable | $9.53 | $10.77 | $8.95 | $9.62 |
| Deferred revenue | ||||
| Short long term debt | $4.69 | $4.13 | $2.72 | $7.57 |
| Total current liabilities | $61.13 | $58.94 | $58.02 | $60.47 |
| Long term debt | $353.53 | $355.49 | $348.5 | $309.8 |
| Total noncurrent liabilities | $445.98 | $449.72 | $439.48 | $400.22 |
| Total debt | $358.22 | $359.62 | $351.22 | $317.37 |
| Total liabilities | $507.11 | $508.66 | $497.5 | $460.69 |
| Shareholders' equity | ||||
| Retained earnings | $22.07 | $11.49 | $13.67 | $20.02 |
| Other shareholder equity | -$5.58 | -$0.57 | -$3.55 | $6.74 |
| Total shareholder equity | $311.54 | $301.83 | $297.33 | $328.71 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $61.41 | $33.77 | $41.49 | $39.98 |
| Short term investments | $0.55 | $0.53 | $0.75 | $0.78 |
| Net receivables | $48.75 | $55.86 | $51.43 | $51.44 |
| Inventory | $73.04 | $53.07 | $45.48 | $46.68 |
| Total current assets | $234.59 | $187.39 | $179.17 | $179.28 |
| Long term investments | ||||
| Property, plant & equipment | $51.65 | $54.14 | $31.03 | $33.58 |
| Goodwill & intangible assets | $487.12 | $344.43 | $348.86 | $367.74 |
| Total noncurrent assets | $554.82 | $418.26 | $391.92 | $410.41 |
| Total investments | $0.55 | $0.53 | $0.75 | $0.78 |
| Total assets | $789.4 | $605.65 | $571.09 | $589.69 |
| Current liabilities | ||||
| Accounts payable | $9.62 | $9.8 | $7.55 | $9.77 |
| Deferred revenue | ||||
| Short long term debt | $7.57 | $7.25 | $1.89 | $1.3 |
| Total current liabilities | $60.47 | $45.2 | $34.52 | $42.94 |
| Long term debt | $309.8 | $237.9 | $221.66 | $225.09 |
| Total noncurrent liabilities | $400.22 | $274.76 | $261.5 | $269.69 |
| Total debt | $317.37 | $245.15 | $223.55 | $226.39 |
| Total liabilities | $460.69 | $319.96 | $296.02 | $312.63 |
| Shareholders' equity | ||||
| Retained earnings | $20.02 | $36.7 | $34.98 | $37.61 |
| Other shareholder equity | $6.74 | -$8.59 | -$6.07 | $1.86 |
| Total shareholder equity | $328.71 | $285.7 | $275.07 | $277.06 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $72.21 | $76.15 | $71.09 | $67.9 |
| Cost of revenue | $24.42 | $25.64 | $23.25 | $23.3 |
| Gross Profit | $47.79 | $50.51 | $47.84 | $44.59 |
| Operating activities | ||||
| Research & development | $9.97 | $8.36 | $7.75 | $6.57 |
| Selling, general & administrative | $39.05 | $40.83 | $38.64 | $36.1 |
| Total operating expenses | $49.02 | $49.19 | $46.39 | $42.68 |
| Operating income | -$1.24 | $1.32 | $1.45 | $1.91 |
| Income from continuing operations | ||||
| EBIT | $12.04 | $2.67 | -$0.46 | $4.63 |
| Income tax expense | -$2.64 | -$0.01 | -$1.36 | $3.37 |
| Interest expense | $4.1 | $4.86 | $4.04 | $4.72 |
| Net income | ||||
| Net income | $10.58 | -$2.18 | -$3.14 | -$3.46 |
| Income (for common shares) | $10.58 | -$2.18 | -$3.14 | -$3.46 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $253.23 | $276.22 | $262.84 | $189.7 |
| Cost of revenue | $85.44 | $93.21 | $89.86 | $61.06 |
| Gross Profit | $167.78 | $183.01 | $172.98 | $128.64 |
| Operating activities | ||||
| Research & development | $24.21 | $22.96 | $23.1 | $19.46 |
| Selling, general & administrative | $141.14 | $143.01 | $140.57 | $101.21 |
| Total operating expenses | $165.34 | $165.97 | $163.67 | $120.67 |
| Operating income | $2.44 | $17.04 | $9.31 | $7.97 |
| Income from continuing operations | ||||
| EBIT | -$0.48 | $16.53 | $9.4 | $8.44 |
| Income tax expense | -$0.49 | -$0.08 | -$3.55 | -$0.14 |
| Interest expense | $16.7 | $14.89 | $15.79 | $4.88 |
| Net income | ||||
| Net income | -$16.68 | $1.72 | -$2.84 | $3.7 |
| Income (for common shares) | -$16.68 | $1.72 | -$2.84 | $3.7 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $10.58 | -$2.18 | -$3.14 | -$3.46 |
| Operating activities | ||||
| Depreciation | $8 | $7.81 | $7.76 | $7.71 |
| Business acquisitions & disposals | $0.52 | |||
| Stock-based compensation | $2.88 | $2.12 | $2.48 | -$0.52 |
| Total cash flows from operations | -$2.91 | $2.65 | -$3.04 | $5.45 |
| Investing activities | ||||
| Capital expenditures | -$3.27 | -$5.75 | -$1.5 | -$2.16 |
| Investments | $19 | |||
| Total cash flows from investing | $15.52 | -$6.23 | -$0.81 | -$2.35 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.14 | $1.44 | -$0.95 | $0.13 |
| Net borrowings | -$0.99 | -$2.92 | -$0.7 | -$1.62 |
| Total cash flows from financing | $0.32 | -$1.64 | -$2.1 | -$1.68 |
| Effect of exchange rate | $1.18 | -$0.85 | $1.09 | -$4.1 |
| Change in cash and equivalents | $14.1 | -$6.08 | -$4.86 | -$2.68 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Net income | -$16.68 | $1.72 | -$2.84 | $3.7 |
| Operating activities | ||||
| Depreciation | $27.86 | $23.33 | $18.09 | $9.74 |
| Business acquisitions & disposals | -$59.12 | -$164.33 | ||
| Stock-based compensation | $6.91 | $8.8 | $6.33 | $6.92 |
| Total cash flows from operations | $12.37 | $15.83 | $9.88 | $10.8 |
| Investing activities | ||||
| Capital expenditures | -$7.33 | -$8.07 | -$5.79 | -$6.63 |
| Investments | $0.06 | |||
| Total cash flows from investing | -$73.13 | -$23.94 | -$6.71 | -$170.99 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.44 | $2.02 | $1.75 | $1.51 |
| Net borrowings | $91.01 | -$2.78 | -$3.41 | $142.64 |
| Total cash flows from financing | $93.61 | -$1.49 | -$2.56 | $143.25 |
| Effect of exchange rate | -$5.18 | $1.67 | $0.88 | $0.28 |
| Change in cash and equivalents | $27.66 | -$7.94 | $1.48 | -$16.66 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 39.33M |
| Revenue | $287.34M |
|---|---|
| EBITDA | $50.17M |
| EBIT | $18.88M |
| Net Income | $1.81M |
| Revenue Q/Q | 10.86% |
| Revenue Y/Y | 12.67% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 8.06 |
| Cash/Share | 1.64 |
| EPS | $0.05 |
|---|---|
| ROA | 0.23% |
| ROE | 0.58% |
| Debt/Equity | 1.40 |
|---|---|
| Net debt/EBITDA | 8.82 |
| Current ratio | 4.21 |
| Quick ratio | 2.93 |